Metraipolis › archive › dc_5ffe1ff2f62d

Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT — Europe PMC PMID:41008852

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41008852
DOI
10.3390/cancers17183008
License (as archived)
solo-consultazione
Archived
2026-11-09T23:20:23.178Z
SHA-256 of the archived text
348c9eebdfd235cd6671fb4b777f63a1a060138d342df74b9b299c35e03abc0b
Stable URL of this page
https://metraipolis.com/documento/dc_5ffe1ff2f62d

How to cite

Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT — Europe PMC PMID:41008852 — Europe PMC (en), https://europepmc.org/article/MED/41008852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ffe1ff2f62d (Metraipolis archive dc_5ffe1ff2f62d, sha256 348c9eebdfd235cd6671fb4b777f63a1a060138d342df74b9b299c35e03abc0b)
BibTeX
@misc{dc5ffe1ff2f62d,
  title = {Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT — Europe PMC PMID:41008852},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41008852},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ffe1ff2f62d; sha256 348c9eebdfd235cd6671fb4b777f63a1a060138d342df74b9b299c35e03abc0b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41008852. Agents can read the archived copy with the MCP tool read_document.